PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2016

Protective Effect of Aliskiren in Experimental Ischemic Stroke: Up-Regulated p-PI3K, p-AKT, Bcl-2 Expression, Attenuated Bax Expression.

Mouse / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 27180190 ↗2016Reported benefit

Protective Effect of Aliskiren in Experimental Ischemic Stroke: Up-Regulated p-PI3K, p-AKT, Bcl-2 Expression, Attenuated Bax Expression.

MouseIschaemia-reperfusionCerebral (MCAO/stroke)C57BL/6MaleIntragastric10 or 25 mg/kg per dayAfter transient middle cerebral artery occlusion

Model: Transient middle cerebral artery occlusion

Aliskiren significantly improved neurological deficit, infarct volume, brain water content and Nissl body counts without altering systemic blood pressure. Protection was associated with reduced apoptosis, increased phosphorylation of PI3K and AKT, higher Bcl-2 and lower Bax, and was reversed by the…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.